TNGX · Tango Therapeutics
AI read · Good for TNGX
The AI's read
This gives Tango a chance to test the drug combination in people. That advances its cancer research, but the study still needs to show whether the treatment is safe and works.
Starting the Phase 1/2 study advances Tango's combination treatment toward testing in people. Safety and benefit are still unproven, but this step moves its cancer research forward.
This gives Tango a chance to test the drug combination in people. That advances its cancer research, but the study still needs to show whether the treatment is safe and works.
Follow Tango Therapeutics (TNGX) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for TNGX